- Home
- BLRX vs RCG Comparison
BLRX vs RCG Comparison
Compare BLRX & RCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- RCG
- Stock Information
- Founded
- BLRX 2003
- RCG 1994
- Country
- BLRX Israel
- RCG United States
- Employees
- BLRX N/A
- RCG N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- RCG Investment Managers
- Sector
- BLRX Health Care
- RCG Finance
- Exchange
- BLRX Nasdaq
- RCG Nasdaq
- Market Cap
- BLRX 15.3M
- RCG 18.2M
- IPO Year
- BLRX 2011
- RCG N/A
- Fundamental
- Price
- BLRX $4.53
- RCG $2.56
- Analyst Decision
- BLRX Strong Buy
- RCG
- Analyst Count
- BLRX 2
- RCG 0
- Target Price
- BLRX $19.00
- RCG N/A
- AVG Volume (30 Days)
- BLRX 217.2K
- RCG 5.9K
- Earning Date
- BLRX 08-14-2025
- RCG 01-01-0001
- Dividend Yield
- BLRX N/A
- RCG 0.98%
- EPS Growth
- BLRX N/A
- RCG N/A
- EPS
- BLRX N/A
- RCG N/A
- Revenue
- BLRX $22,340,000.00
- RCG N/A
- Revenue This Year
- BLRX N/A
- RCG N/A
- Revenue Next Year
- BLRX N/A
- RCG N/A
- P/E Ratio
- BLRX N/A
- RCG N/A
- Revenue Growth
- BLRX 91.68
- RCG N/A
- 52 Week Low
- BLRX $2.30
- RCG $1.52
- 52 Week High
- BLRX $35.60
- RCG $1.90
- Technical
- Relative Strength Index (RSI)
- BLRX 52.05
- RCG 47.94
- Support Level
- BLRX $4.20
- RCG $2.55
- Resistance Level
- BLRX $4.62
- RCG $2.66
- Average True Range (ATR)
- BLRX 0.43
- RCG 0.08
- MACD
- BLRX -0.09
- RCG -0.00
- Stochastic Oscillator
- BLRX 34.42
- RCG 33.33
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About RCG RENN Fund Inc
RENN Fund Inc is active in the financial services domain. It is a a registered, non-diversified, closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, oil and gas, medical chemicals, botanical products, etc.